IFP Advisors’s Mersana Therapeutics MRSN Stock Holding History

IFP Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$87	–	5237
2026 Q1	$87	Hold	3	–	–	﹤0.01%	4762
2025 Q4	$87	Sell	3 -612	-100%	-$11.6K	﹤0.01%	4618
2025 Q3	$227	Buy	615 +588	+2,178%	+$4.41K	﹤0.01%	4371
2025 Q2	$201	Buy	+27	New	+$237	﹤0.01%	4627
2025 Q1	–	Hold	0	–	-$3	–	4526
2024 Q4	–	Hold	0	–	–	–	4576
2022 Q4	–	Sell	-72	Closed	-$36K	–	4740
2022 Q3	$36K	Buy	+72	New	+$11.7K	﹤0.01%	2636

IFP Advisors's MRSN Position: Q2 2026 in Review

IFP Advisors sold out of Mersana Therapeutics (MRSN) in Q2 2026, closing a stake of 3 shares — an estimated $87 sold.

IFP Advisors first reported a position in MRSN in Q3 2022 and held it in 5 quarters. The position peaked at $36K in Q3 2022. 0 funds tracked by Wall St. Rank hold MRSN as of Q2 2026.

IFP Advisors reported no remaining Mersana Therapeutics position as of Q2 2026 after selling out during the quarter.
IFP Advisors sold 3 Mersana Therapeutics shares in Q2 2026, an estimated $87.
IFP Advisors first reported a position in Mersana Therapeutics in Q3 2022 and held it in 5 quarters.
IFP Advisors's Mersana Therapeutics position peaked at $36K in Q3 2022.
0 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.